help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 63, No. 1 208-214
doi:10.1210/jcem-63-1-208
Copyright © 1986 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZOLA, B.
Right arrow Articles by VINIK, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZOLA, B.
Right arrow Articles by VINIK, A. I.

Abnormal Cardiac Function in Diabetic Patients with Autonomic Neuropathy in the Absence of Ischemic Heart Disease*

BENJAMIN ZOLA, JOEL K. KAHN, JACK E. JUNI and AARON I. VINIK

Department of Internal Medicine, Divisions of Endocrinology and Metabolism and Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109

Address requests for reprints to:Aaron I.Vinik, MD., University of Michigan Medical Center, 2922B Taubman Health Care Center, Ann Arbor, Michigan 48109.

To determine if cardiac autonomic neuropathy CAN) contributes to diabetic cardiomyopathy, left ventricular function was assessed by resting and exercise radionuclide ventriculography (RVG) in 30 patients with long-standing insulindependent diabetes mellitus who had no clinical, electrocardiographic, or tomographic thallium scan evidence of heart disease. In 11 of 30 patients (37%), RVG revealed abnormal left ventricularperformance* CAN was found in 91% of these patients. RVG was abnormal in 59% of patients with CAN and in only 8% of patients without CAN (P <0.005). There were significant reductions in mean (±SE) ejection fractions (EF) in patients with CAN at rest (62.8 ± 2.2% vs. 75.2 ± 2.5%; P <0.001) and with maximal exercise (65.8 ± 2.6% vs. 80.9 ± 2.3%; P <0.001) compared to patients without CAN. There was an inverse correlation between the autonomic function score and both resting EF (r = -0.53; P <0.002) and exercise EF (r = -0.55; P <0.002). Systolic function did not correlate with age, sex, duration or control of diabetes, microvascular complications, or plasma norepinephrine levels.

Thus, approximately one third of our study population had evidence for depressed left ventricular function in the absence of ischemic heart disease, and the cardiac dysfunction was related to the severity of CAN. CAN may be a contributor to cardiac dysfunction in diabetes mellitus.

* This work was supprted by grants to the Clinical Research Center (5M01-RR-00042-22)and the Michigan Diabetes Research and Training Center (AM-20572-07).

Received December 20, 1985.




This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
A. Stefanidis, S. Bousboulas, J. Kalafatis, K. Baroutsi, P. Margos, K. Komninos, S. Pappas, and E. Papasteriadis
Left ventricular anatomical and functional changes with ageing in type 2 diabetic adults
Eur J Echocardiogr, July 1, 2009; 10(5): 647 - 653.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Kusmic, S. Morbelli, C. Marini, M. Matteucci, C. Cappellini, E. Pomposelli, P. Marzullo, A. L'Abbate, and G. Sambuceti
Whole-Body Evaluation of MIBG Tissue Extraction in a Mouse Model of Long-Lasting Type II Diabetes and Its Relationship with Norepinephrine Transport Protein Concentration
J. Nucl. Med., October 1, 2008; 49(10): 1701 - 1706.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): 652 - 726.
[Full Text] [PDF]


Home page
PNHome page
A. A Little, J. L Edwards, and E. L Feldman
Diabetic neuropathies
Practical Neurology, April 1, 2007; 7(2): 82 - 92.
[Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
C. Patel, K. L Wyne, and D. K McGuire
Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?
Diabetes and Vascular Disease Research, May 1, 2005; 2(2): 61 - 66.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
H. S. Lim, R. J. MacFadyen, and G. Y. H. Lip
Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart
Arch Intern Med, September 13, 2004; 164(16): 1737 - 1748.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Z. Y. Fang, J. B. Prins, and T. H. Marwick
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Endocr. Rev., August 1, 2004; 25(4): 543 - 567.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
L. A. Scott and P. L. Kench
Cardiac Autonomic Neuropathy in the Diabetic Patient: Does 123I-MIBG Imaging Have a Role to Play in Early Diagnosis?
J. Nucl. Med. Technol., June 1, 2004; 32(2): 66 - 71.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. F. Johnson, R. W. Nesto, M. A. Pfeifer, W. R. Slater, A. I. Vinik, D. A. Chyun, G. Law, F. J.Th. Wackers, and L. H. Young
Cardiac Abnormalities in Diabetic Patients With Neuropathy: Effects of aldose reductase inhibitor administration
Diabetes Care, February 1, 2004; 27(2): 448 - 454.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. I M Al-Shafei, R G Wise, G A Gresham, T A Carpenter, L D Hall, and C. L-H Huang
Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition
J. Physiol., January 15, 2002; 538(2): 555 - 572.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al.
ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)
J. Am. Coll. Cardiol., September 1, 2000; 36(3): 970 - 1062.
[Full Text] [PDF]


Home page
HypertensionHome page
Z. Pietrzyk, S. Vogel, G. J. Dietze, and S. F. Rabito
Augmented Sympathetic Response to Bradykinin in the Diabetic Heart Before Autonomic Denervation
Hypertension, August 1, 2000; 36(2): 208 - 214.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Stevens, D. M. Raffel, K. C. Allman, F. Dayanikli, E. Ficaro, T. Sandford, D. M. Wieland, M. A. Pfeifer, and M. Schwaiger
Cardiac Sympathetic Dysinnervation in Diabetes : Implications for Enhanced Cardiovascular Risk
Circulation, September 8, 1998; 98(10): 961 - 968.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Bernbaum, S. G. Albert, and J. D. McGarry
Diabetic Neuropathy and Braille Ability
Arch Neurol, November 1, 1989; 46(11): 1179 - 1181.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
Y. HARATI
Diabetic Peripheral Neuropathies
Ann Intern Med, October 1, 1987; 107(4): 546 - 559.
[Abstract] [PDF]


Home page
J. Physiol.Home page
A. I M Al-Shafei, R G Wise, G A Gresham, T A Carpenter, L D Hall, and C. L-H Huang
Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition
J. Physiol., January 15, 2002; 538(2): 555 - 572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society